|
Post by matt on Jan 27, 2016 13:57:12 GMT -5
I can pretty much guarantee the bank will come up with a briefing book that offers to sell MNKD in one piece, or to offer up the pieces. TS is a drug delivery device and pharmas don't like licensing devices from competitors or even perceived competitors. The TS technology would do better in a separate company, preferably one with other delivery technologies, than with a pharma company.
Afrezza belongs with a drug company with a field sales force large enough to promote it. That list is not that long, and the list of companies with large field sales forces and established call points in primary care offices is even shorter.
The best play for shareholder might be to sell both Afrezza and TS and convert the company to a royalty trust, effectively converting shares to trust units. The trust could enjoy royalties during the remaining patent life and then self-liquidate. Not a traditional way to get the best value from these assets, but it may be the best way.
|
|
|
Post by dreamboatcruise on Jan 27, 2016 14:09:31 GMT -5
I can pretty much guarantee the bank will come up with a briefing book that offers to sell MNKD in one piece, or to offer up the pieces. TS is a drug delivery device and pharmas don't like licensing devices from competitors or even perceived competitors. The TS technology would do better in a separate company, preferably one with other delivery technologies, than with a pharma company. Afrezza belongs with a drug company with a field sales force large enough to promote it. That list is not that long, and the list of companies with large field sales forces and established call points in primary care offices is even shorter. The best play for shareholder might be to sell both Afrezza and TS and convert the company to a royalty trust, effectively converting shares to trust units. The trust could enjoy royalties during the remaining patent life and then self-liquidate. Not a traditional way to get the best value from these assets, but it may be the best way. Matt... sounds like you need to get in touch with Matt.
|
|
|
Post by dreamboatcruise on Jan 27, 2016 14:15:57 GMT -5
You know what the issue is with MannKind? Everyone wants a magical solution to their problems and everyone refuses to believe in magic. (paraphrasing the Mad Hatter from Alice in Wonderland) I've often wondered whether my behavior in investing in MNKD had something to do with mercury poisoning. Would you like a little more tea?
|
|
|
Post by BlueCat on Jan 27, 2016 14:30:05 GMT -5
They've engaged an IB and they told investors they are exploring all opportunities. The IB has undoubtedly been tasked with exactly that. The only question is whether in answering this poll yes or no you are wanting us to weigh in on Al's state of mind regarding likelihood of agreeing to a buyout anywhere near what is realistic price. Even if management hadn't said they were exploring all opportunities, I think it would be a breach of their fiduciary duties to not be at this point... and having said they are would add a layer of deception if they are not.kc ... yes... you are correct $10 would be "nice"... sort of like it would be "nice" if I had won that billion dollar lottery. I think realistically, they have to consider all options. But importantly, with all these spawning lawyer PRs on breach of duty. If they did not, lawyers would have a field day, "case closed". Geez. Reminds me of B. Clinton's joke years ago after the impeachment scandal when he said he'd log into AOL and hear, "You've got subpoenas" ....
|
|
|
Post by nemzter on Jan 27, 2016 14:32:09 GMT -5
What about the following: 1. Company sale 2. Afrezza sale 3. Technosphere sale 4. Bankruptcy 5. Dilution 6. Hakan thinking, damn I should of sold all my shares at $5 All options are definitely on the table
|
|
|
Post by mindovermatter on Jan 27, 2016 14:34:07 GMT -5
They've engaged an IB and they told investors they are exploring all opportunities. The IB has undoubtedly been tasked with exactly that. The only question is whether in answering this poll yes or no you are wanting us to weigh in on Al's state of mind regarding likelihood of agreeing to a buyout anywhere near what is realistic price. Even if management hadn't said they were exploring all opportunities, I think it would be a breach of their fiduciary duties to not be at this point... and having said they are would add a layer of deception if they are not.kc ... yes... you are correct $10 would be "nice"... sort of like it would be "nice" if I had won that billion dollar lottery. I think realistically, they have to consider all options. But importantly, with all these spawning lawyer PRs on breach of duty. If they did not, lawyers would have a field day, "case closed". Geez. Reminds me of B. Clinton's joke years ago after the impeachment scandal when he said he'd log into AOL and hear, "You've got subpoenas" .... The company needs money desperately. If they can find a suitable buyer for Afrezza, one that they believe can do the leg work that Sanofi was unwilling to do to make Afrezza successful, I believe they will sell it to that company so that it can use the money to further TS applications. IMO Afrezza, sad to say, is a anchor around the neck of this company.
|
|
|
Post by kc on Jan 27, 2016 14:59:22 GMT -5
MAGICAL SOLUTION no more dilution and have plenty of cash to market and sell Afrezza. That means a BO or Buy out. MannKind needs a new beginning with a strong financial backing.
|
|
|
Post by mpg54 on Jan 27, 2016 16:06:05 GMT -5
They've engaged an IB and they told investors they are exploring all opportunities. The IB has undoubtedly been tasked with exactly that. The only question is whether in answering this poll yes or no you are wanting us to weigh in on Al's state of mind regarding likelihood of agreeing to a buyout anywhere near what is realistic price. Even if management hadn't said they were exploring all opportunities, I think it would be a breach of their fiduciary duties to not be at this point... and having said they are would add a layer of deception if they are not. kc ... yes... you are correct $10 would be "nice"... sort of like it would be "nice" if I had won that billion dollar lottery. if not $10, what do you think is possible? $3-$4?
|
|
|
Post by dreamboatcruise on Jan 27, 2016 20:48:07 GMT -5
They've engaged an IB and they told investors they are exploring all opportunities. The IB has undoubtedly been tasked with exactly that. The only question is whether in answering this poll yes or no you are wanting us to weigh in on Al's state of mind regarding likelihood of agreeing to a buyout anywhere near what is realistic price. Even if management hadn't said they were exploring all opportunities, I think it would be a breach of their fiduciary duties to not be at this point... and having said they are would add a layer of deception if they are not. kc ... yes... you are correct $10 would be "nice"... sort of like it would be "nice" if I had won that billion dollar lottery. if not $10, what do you think is possible? $3-$4? Someone was making the case that an acquirer would only pay 50% premium over trading price. I wouldn't be that pessimistic. Ideally there is more than one player interested. In that case the street would catch wind and the share price could start rising. Then, yes, maybe it is only bought out at 50% premium but gets us at least closer to your range. If we don't have a price increase much beyond here, I think we good get a premium higher than 50% since there is legitimately a big bankruptcy risk haircut built into the price which doesn't devalue the asset to an acquirer. But I'd sure think it would start getting tough to justify more than 100% to the acquirers shareholders. Let's just say I would be VERY thankful if we have a near term buyout that got me my $4.38 average price. Maybe there are some scenarios that are not total buyout that could yield a profit for me, but that isn't going to happen if there is a complete acquisition now... IMHO.
|
|
|
Post by dreamboatcruise on Jan 27, 2016 20:50:45 GMT -5
I think realistically, they have to consider all options. But importantly, with all these spawning lawyer PRs on breach of duty. If they did not, lawyers would have a field day, "case closed". Geez. Reminds me of B. Clinton's joke years ago after the impeachment scandal when he said he'd log into AOL and hear, "You've got subpoenas" .... The company needs money desperately. If they can find a suitable buyer for Afrezza, one that they believe can do the leg work that Sanofi was unwilling to do to make Afrezza successful, I believe they will sell it to that company so that it can use the money to further TS applications. IMO Afrezza, sad to say, is a anchor around the neck of this company. Yikes... do I need to change my name from dreamboatcruise to dreamboatanchor? I am feeling that I set out for a 3 hour cruise and got shipwrecked.
|
|
|
Post by mnholdem on Jan 27, 2016 21:05:28 GMT -5
Hang in there, little buddy!
|
|
|
Post by mindovermatter on Jan 28, 2016 5:13:16 GMT -5
The company needs money desperately. If they can find a suitable buyer for Afrezza, one that they believe can do the leg work that Sanofi was unwilling to do to make Afrezza successful, I believe they will sell it to that company so that it can use the money to further TS applications. IMO Afrezza, sad to say, is a anchor around the neck of this company. Yikes... do I need to change my name from dreamboatcruise to dreamboatanchor? I am feeling that I set out for a 3 hour cruise and got shipwrecked. Hopefully you have Maryanne and Ginger to console you. My wife slaps me every time I utter their names in my sleep. And in deed, hang in there little buddy.
|
|